Maternal consumption of a high-fat diet (HFD) during pregnancy and lactation is closely related to hepatic lipid accumulation, insulin resistance and increased serum cytokine levels in offspring and into their adulthood. MicroRNA (miRNA) have been implicated in cholesterol biosynthesis and fatty acid metabolism. We evaluated the modulation of hepatic fatty acid synthesis (de novo), β-oxidation pathways, and miRNA-122 (miR-122) and miRNA-370 (miR-370) expression in recently weaned offspring (day 28) of mouse dams fed a HFD (HFD-O) or a standard chow (SC-O) during pregnancy and lactation. Compared with SC-O mice, HFD-O mice weighed more, had a larger adipose tissue mass and were more intolerant to glucose and insulin (P< 0·05). HFD-O mice also presented more levels of serum cholesterol, TAG, NEFA and hepatic IκB kinase and c-Jun N-terminal kinase phosphorylation compared with SC-O mice (P< 0·05). Protein levels of fatty acid synthase, acetyl-CoA carboxylase and 3-hydroxy-3-methylglutaryl-CoA reductase were similar in HFD-O and SC-O mice, whereas expression levels of SCD1 mRNA and protein were more abundant in HFD-O mice than in SC-O mice (P< 0·05). Interestingly, mRNA expression levels of the β-oxidation-related genes ACADVL and CPT1 were decreased in HFD-O mice (P< 0·05). Furthermore, the expression of miR-122 was reduced but that of miR-370 was increased in HFD-O mice compared with that in SC-O mice (P< 0·05). Changes in hepatic lipid metabolism were accompanied by increased mRNA content of AGPAT1 and TAG deposition in HFD-O mice (P< 0·05). Taken together, the present results strongly suggest that maternal consumption of a HFD affects the early lipid metabolism of offspring by modulating the expression of hepatic β-oxidation-related genes and miRNA that can contribute to metabolic disturbances in adult life. © The Authors 2014.1111221122122Danielzik, S., Langnase, K., Mast, M., Impact of parental BMI on the manifestation of overweight 5-7 year old children (2002) Eur J Nutr, 41, pp. 132-138Boney, C.M., Verma, A., Tucker, R., Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus (2005) Pediatrics, 115, pp. e290-e296Catalano, P.M., Farrell, K., Thomas, A., Perinatal risk factors for childhood obesity and metabolic dysregulation (2009) Am J Clin Nutr, 90, pp. 1303-1313Challier, J.C., Basu, S., Bintein, T., Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta (2008) Placenta, 29, pp. 274-281Elahi, M.M., Cagampang, F.R., Mukhtar, D., Longterm maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice (2009) Br J Nutr, 102, pp. 514-519Ashino, N.G., Saito, K.N., Souza, F.D., Maternal highfat feeding through pregnancy and lactation predisposes mouse offspring to molecular insulin resistance and fatty liver (2012) J Nutr Biochem, 23, pp. 341-348Shankar, K., Zhong, Y., Kang, P., Maternal obesity promotes a proinflammatory signature in rat uterus and blastocyst (2011) Endocrinology, 152, pp. 4158-4170Qureshi, K., Abrams, G.A., Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease (2007) World J Gastroenterol, 13, pp. 3540-3553Stanton, M.C., Chen, S.C., Jackson, J.V., Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice (2011) J Inflamm (Lond, 8, p. 8Mc Curdy, C.E., Bishop, J.M., Williams, S.M., Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates (2009) J Clin Invest, 119, pp. 323-335Heerwagen, M.J., Stewart, M.S., De La Houssaye, B.A., Transgenic increase in n-3/n-6 fatty acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice (2013) PLOS ONE, 8, pp. e67791Postic, C., Girard, J., The role of the lipogenic pathway in the development of hepatic steatosis (2008) Diabetes Metab, 34, pp. 643-648Bouanane, S., Merzouk, H., Benkalfat, N.B., Hepatic and very low-density lipoprotein fatty acids in obese offspring of overfed dams (2010) Metabolism, 59, pp. 1701-1709Waterland, R.A., Does nutrition during infancy and early childhood contribute to later obesity via metabolic imprinting of epigenetic gene regulatory mechanisms (2005) Nestle Nutr Workshop ser Pediatr Program, 56, pp. 157-171. , discussion 171-154Sullivan, E.L., Grove, K.L., Metabolic imprinting in obesity (2010) Forum Nutr, 63, pp. 186-194Bartel, D.P., Micro RNAs: Genomics, biogenesis, mechanism, and function (2004) Cell, 116, pp. 281-297Li, Z.Y., Xi, Y., Zhu, W.N., Positive regulation of hepatic miR-122 expression by HNF4a (2011) J Hepatol, 55, pp. 602-611Yang, Y.M., Seo, S.Y., Kim, T.H., Decrease of micro-RNA-122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid (2012) Hepatology, 56, pp. 2209-2220Iliopoulos, D., Drosatos, K., Hiyama, Y., Micro RNA-370 controls the expression of microRNA-122 and Cpt1a and affects lipid metabolism (2010) J Lipid Res, 51, pp. 1513-1523Dell, R.B., Holleran, S., Ramakrishnan, R., Sample size determination (2002) ILAR J, 43, pp. 207-213Carr, T.P., Andresen, C.J., Rudel, L.L., Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts (1993) Clin Biochem, 26, pp. 39-42Newberry, E.P., Xie, Y., Kennedy, S., Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene (2003) J Biol Chem, 278, pp. 51664-51672Bonora, E., Zavaroni, I., Alpi, O., Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects (1987) Diabetologia, 30, pp. 719-723Stenseth, N.C., Viljugrein, H., Saitoh, T., Seasonality, density dependence, and population cycles in Hokkaido voles (2003) Proc Natl Acad Sci USA, 100, pp. 11478-11483Shoelson, S.E., Lee, J., Yuan, M., Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity-and dietinduced insulin resistance (2003) Int J Obes Relat Metab Disord, 27 (SUPPL. 3), pp. S49-S52Cnop, M., Fatty acids and glucolipotoxicity in the pathogenesis of type 2 diabetes (2008) Biochem Soc Trans, 36, pp. 348-352Araujo, E.P., Torsoni, M.A., Velloso, L.A., Hypothalamic inflammation and obesity (2010) Vitam Horm, 82, pp. 129-143Donath, M.Y., Shoelson, S.E., Type 2 diabetes as an inflammatory disease (2011) Nat Rev Immunol, 11, pp. 98-107Gregor, M.F., Hotamisligil, G.S., Inflammatory mechanisms in obesity (2011) Annu Rev Immunol, 29, pp. 415-445Horng, T., Hotamisligil, G.S., Linking the inflammasome to obesity-related disease (2011) Nat Med, 17, pp. 164-165Velloso, L.A., Schwartz, M.W., Altered hypothalamic function in diet-induced obesity (2011) Int J Obes (Lond, 35, pp. 1455-1465Levin, B.E., Interaction of perinatal and pre-pubertal factors with genetic predisposition in the development of neural pathways involved in the regulation of energy homeostasis (2010) Brain Res, 1350, pp. 10-17Barbuio, R., Milanski, M., Bertolo, M.B., Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet (2007) J Endocrinol, 194, pp. 539-550Cintra, D.E., Pauli, J.R., Araujo, E.P., Interleukin-10 is a protective factor against diet-induced insulin resistance in liver (2008) J Hepatol, 48, pp. 628-637Wiedemann, M.S., Wueest, S., Item, F., Adipose tissue inflammation contributes to short-term high-fat dietinduced hepatic insulin resistance (2013) Am J Physiol Endocrinol Metab, 305, pp. E388-E395Turner, N., Kowalski, G.M., Leslie, S.J., Distinct patterns of tissue-specific lipid accumulation during the induction of insulin resistance in mice by high-fat feeding (2013) Diabetologia, 56, pp. 1638-1648Kraegen, E.W., Cooney, G.J., Free fatty acids and skeletal muscle insulin resistance (2008) Curr Opin Lipidol, 19, pp. 235-241Samuel, V.T., Shulman, G.I., Mechanisms for insulin resistance: Common threads and missing links (2012) Cell, 148, pp. 852-871Farese Jr., R.V., Zechner, R., Newgard, C.B., The problem of establishing relationships between hepatic steatosis and hepatic insulin resistance (2012) Cell Metab, 15, pp. 570-573Brown, M.S., Goldstein, J.L., Selective versus total insulin resistance: A pathogenic paradox (2008) Cell Metab, 7, pp. 95-96Jiang, G., Li, Z., Liu, F., Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1 (2005) J Clin Invest, 115, pp. 1030-1038Yokoyama, S., Hosoi, T., Ozawa, K., Stearoyl-CoA desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice (2012) Gene, 497, pp. 340-343Hodson, L., Fielding, B.A., Stearoyl-CoA desaturase: Rogue or innocent bystander (2013) Prog Lipid Res, 52, pp. 15-42Takeuchi, K., Reue, K., Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis (2009) Am J Physiol Endocrinol Metab, 296, pp. E1195-E1209Hsu, S.H., Wang, B., Kota, J., Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver (2012) J Clin Invest, 122, pp. 2871-2883Yu, H., Bi, Y., Ma, W., Long-term effects of high lipid and high energy diet on serum lipid, brain fatty acid composition, and memory and learning ability in mice (2010) Int J Dev Neurosci, 28, pp. 271-276Silber, G.H., Hachey, D.L., Schanler, R.J., Manipulation of maternal diet to alter fatty acid composition of human milk intended for premature infants (1988) Am J Clin Nutr, 47, pp. 810-814Priego, T., Sanchez, J., Garca, A.P., Maternal dietary fat affects milk fatty acid profile and impacts on weight gain and thermogenic capacity of suckling rats (2013) Lipids, 48, pp. 481-495Lewis, G.F., Carpentier, A., Adeli, K., Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes (2002) Endocr Rev, 23, pp. 201-229Ferre, P., Foufelle, F., Hepatic steatosis: A role for de novo lipogenesis and the transcription factor SREBP-1c (2010) Diabetes Obes Metab, 12 (SUPPL. 2), pp. 83-92Donnelly, K.L., Smith, C.I., Schwarzenberg, S.J., Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease (2005) J Clin Invest, 115, pp. 1343-1351Esau, C., Davis, S., Murray, S.F., MiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting (2006) Cell Metab, 3, pp. 87-98Li, S., Chen, X., Zhang, H., Differential expression of microRNAs in mouse liver under aberrant energy metabolic status (2009) J Lipid Res, 50, pp. 1756-1765Whittaker, R., Loy, P.A., Sisman, E., Identification of microRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening (2010) J Biomol Screen, 15, pp. 798-805Rayner, K.J., Sheedy, F.J., Esau, C.C., Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis (2011) J Clin Invest, 121, pp. 2921-2931Aranda, J.F., Madrigal-Matute, J., Rotllan, N., MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases (2013) Free Radic Biol Med, 64, pp. 31-39Tsai, W.C., Hsu, S.D., Hsu, C.S., Micro RNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis (2012) J Clin Invest, 122, pp. 2884-2897Krutzfeldt, J., Rajewsky, N., Braich, R., Silencing of microRNAs in vivo with ?antagomirs? (2005) Nature, 438, pp. 685-689Elmen, J., Lindow, M., Schutz, S., LNA-mediated micro-RNA silencing in non-human primates (2008) Nature, 452, pp. 896-899